Revenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a year ago, it added.from Stocks-Markets-Economic Times https://ift.tt/3iIKcjG
Jubilant Pharmova Q1 results: Co posts net profit of Rs 160 crore
Revenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a year ago, it added.from Stocks-Markets-Economic Times https://ift.tt/3iIKcjG
Related Posts:
Fall in outward remittances good news for India's current account- Yes, winning the Euros really can help your stock market
- How Chinese clampdown will target offshore listings
- Sebi relaxes advance intimation timeliness for bourses to modify commodity derivatives contracts
- Fed's 'substantial' progress goal not yet met in June, minutes show
0 Comments:
Post a Comment